<DOC>
	<DOCNO>NCT01786720</DOCNO>
	<brief_summary>The propose study evaluate ( newly diagnose Chronic Obstructive Pulmonary Disease ( COPD ) patient ) time take prescription triple therapy aim answer follow research question : 1 . The percentage patient prescribed triple therapy , first start receive triple therapy . 2 . For patient prescribed triple therapy , time take triple therapy initial diagnosis COPD . 3 . The variation treatment pathway . 4 . The factor associate time take triple therapy .</brief_summary>
	<brief_title>Analysis Time Taken Triple Therapy ( NOVARTIS )</brief_title>
	<detailed_description>Triple therapy consist long-acting beta agonist ( LABA ) + inhaled corticosteroid ( ICS ) + long-acting muscarinic antagonist ( LAMA ) typically reserve patient severe severe ( FEV1 &lt; 50 % ) COPD symptoms patient two exacerbation per year . However previous research RiRL indicate 50 % patient GOLD stage II ( moderate ) receive ICS half triple therapy . To allow multiple analysis regard factor influence likelihood prescribed triple therapy , bespeak COPD dataset create include : 1 . Disease severity marker : 2 . Confirmation COPD diagnosis initial date COPD diagnosis 3 . Standard co-morbidities field 4 . Demographic field This retrospective , observational study use data COPD patient assess treatment pathway ( changes/step ) initial date COPD diagnosis prescription triple therapy endpoint . Specific question ask : 1 . Does percentage COPD patient prescribed triple therapy vary dependent time initial date COPD diagnosis ? 2 . Does time take prescription triple therapy vary dependent initial date COPD diagnosis ?</detailed_description>
	<criteria>Aged â‰¥40 year initial date COPD diagnosis COPD diagnosis Quality Outcome Framework ( QoF ) approve read code spirometry data supportive COPD diagnosis 5 year around initial date diagnosis COPD ( FEV1 % predict ) Patient one year data prior initial date COPD diagnosis Patient minimum two year data post initial date COPD diagnosi Patients whose initial date COPD diagnosis 1997</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2014</verification_date>
	<keyword>COPD</keyword>
	<keyword>Triple Therapy</keyword>
	<keyword>ICS</keyword>
	<keyword>LABA</keyword>
	<keyword>LAMA</keyword>
</DOC>